文章基本信息
- 标题：The Short-term Effect of Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy
- 本地全文：下载
- 作者：Kim, Hyoung-Seok ; Lee, Jae Heung
- 期刊名称：Journal of the Korean Ophthalmological Society
- 印刷版ISSN：0378-6471
- 出版年度：2010
- 卷号：51
- 期号：6
- 页码：860-864
- DOI：10.3341/jkos.2010.51.6.860
- 语种：Korean
- 出版社：The Korean Ophthalmological Society
- 摘要：Purpose
To determine whether intravitreal bevacizumab is effective for the treatment of central serous chorioretinopathy.
MethodsWe retrospectively examined 42 eyes after intravitreal bevacizumab (1.25 mg) injection for central serous chorioretinopathy. After 1 month, improvement of vision and change in sensory retinal detachment were evaluated with a fundus examination and optical coherence tomography.
ResultsThe mean duration of symptoms was 3.9±2.31 months. After intravitreal bevacizumab injection, mean best corrected visual acuity improved from 0.53±0.31 to 0.72±0.29 at 1 month. In addition, neurosensory retinal detachment disappeared in 32 patients (76.2%). Five patients among ten who did not show improvement of neurosensory retinal detachment underwent reinjection of bevaczumab, and three of those reinjected showed the resolution of neurosensory retinal detachment at another 1 month. No improvement was seen among the patients who did not undergo reinjection.
ConclusionsIntravitreal bevacizumab injection appears to have a short-term benefit for the treatment of central serous chorioretinopathy.
- 关键词：Bevacizumab; Central serous chorioretinopathy
